Julie Xing

Julie Xing is a global executive with over 20 years of experience in the pharmaceutical, medtech, and digital health sectors. Currently serving as a member of the Board of Directors at both Mars Incorporated and Aptar Group, Julie also holds the position of Executive Chair of China on the Board of Directors at Mundipharma. Past roles include leadership positions at Eli Lilly and Company and Envista Holdings Corporation, where they successfully drove business transformation and market access strategies. Julie earned a Doctor of Philosophy (Ph.D.) in Biological Sciences from The Hong Kong University of Science and Technology.